The importance of adjuvant treatment and primary anatomical site in head and neck basaloid squamous cell carcinoma survi

  • PDF / 1,064,256 Bytes
  • 11 Pages / 595.276 x 790.866 pts Page_size
  • 12 Downloads / 207 Views

DOWNLOAD

REPORT


RESEARCH ARTICLE

The importance of adjuvant treatment and primary anatomical site in head and neck basaloid squamous cell carcinoma survival: an analysis of the National Cancer Database J. Gootee1   · M. Patel1 · S. Aurit2 · P. Silberstein3 Received: 5 December 2019 / Accepted: 1 May 2020 © Federación de Sociedades Españolas de Oncología (FESEO) 2020

Abstract Purpose  Basaloid squamous cell carcinoma (BSCC) of the head and neck is an aggressive and highly malignant variant of squamous cell carcinoma that accounts for 2% of head and neck cancers. Previous studies have not analyzed the significance of adjuvant chemoradiation and anatomical site within BSCC subtype and its impact on survival. Methods  A cohort of 1999 patients with BSCC of the head and neck was formed from the National Cancer Database and analyzed with descriptive studies, median survival and 5- and 10-year survival. A multivariable Cox hazard regression was performed to determine the prognostic significance of anatomical site and adjuvant therapy. Results  The most common primary anatomical site was the oropharynx (71.9%) followed by oral cavity (11.5%), larynx (10.1%), hypopharynx (3.5%), esophagus (1.9%), and nasopharynx (1.1%). The presence of metastasis increased the risk of mortality (HR = 2.14; 95% CI 1.40–3.26). Tumors localized to the oropharynx demonstrated better survival compared to all sites except nasopharynx, including the oral cavity (HR = 2.45; 95% CI 1.83–3.29), hypopharynx (HR = 2.58; 95% CI:1.64–4.05), and larynx (HR = 2.89; 95% CI:2.25–3.73). Adjuvant chemoradiation (HR = 0.36; 95% CI 0.23–0.58) and adjuvant radiation (HR = 0.38; 95% CI 0.23–0.64) had better survival outcomes compared to adjuvant chemotherapy. Patients with microscopic margins had better survival outcomes when compared to no surgery (HR = 0.38, 98% Cl 0.23–0.64) while there were no better survival outcomes of patients with macroscopic margins compared to no surgery. Conclusion  This study illustrated that tumors in the oropharynx, lower age, adjuvant chemoradiation and radiation, and microscopic margins were associated with greater survival. Keywords  Anatomical site · Adjuvant therapy · Basaloid squamous cell carcinoma · NCDB · Survival

Introduction Basaloid squamous cell carcinoma (BSCC) was originally described in 1986 by Wain as an atypical subtype of squamous cell carcinoma (SCC) that is estimated to comprise approximately 2% of all head and neck cancers [1, 2]. BSCC * J. Gootee [email protected] 1



Creighton University School of Medicine, 2500 California Plaza, Omaha, NE 68178, USA

2



Division of Clinical Research and Evaluative Sciences, Creighton University School of Medicine, Omaha, NE, USA

3

Division of Hematology/Oncology, Department of Internal Medicine, Creighton University Medical Center, Omaha, NE, USA



can affect a wide variety of anatomical sites including the lungs, buccal mucosa, mandible, the pinna and the uterine cervix [3–7]. Among the different squamous cell carcinomas of the head and neck, BSCC is notorious for dis